This requires the small GTPase Arl8b rather than Rab7 or AP‐3, indicating that VPS41, through different interaction partners, can trigger divergent neuroprotective mechanisms against Parkinson’s disease and Alzheimer’s disease (Griffin etal, 2018). Here, VPS41 is linked to Parkinson disease.